explore -WSS

explore

author：comprehensive 2025-10-02 20:52:33 - browse：846

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Apple Watch's A

WSS

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Truvian presents data for its desktop blood

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Study: AI not yet building 'n

Device maker Teleflex to acquire urology company for $600M

H5N1 communication has been strictly for the birds

focus

explore

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

DIEP, the 'gold standard' of breast reconstruction, is under threat

Device maker Teleflex to acquire urology company for $600M

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: brain research, obesity drug sales, Novartis

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The battle over 'scope creep' and who gets to be called 'doctor'

Bright Health sells Medicare Advantage business to Molina

Biden warns of ‘dark winter’ during final presidental debate

focus

Sanofi strikes deal with Novavax, boosting the vaccine maker

H5N1 communication has been strictly for the birds

What it's like to live with paralysis for one psychologist

How to improve immunocompromised access to mAb treatments

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Why patients can’t get everything they want on drug pricing

knowledge

hotspot

knowledge

hotspot